世界の神経内分泌腫瘍市場 – 2031 年までの業界動向と予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Pharmaceutical 世界の神経内分泌腫瘍市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

世界の神経内分泌腫瘍市場 – 2031 年までの業界動向と予測

  • Pharmaceutical
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 ページ
  • テーブル数: 220
  • 図の数: 60
Buy Now 今すぐ購入

>世界の神経内分泌腫瘍市場、分類別（機能的網および非機能的網）、部位別（肺、膵臓、消化管（GI）、および虫垂）、グレード別（グレード1、グレード2、およびグレード3）、タイプ別（診断および治療）、製品別（ソマトスタチン類似体、標的療法、および化学療法）、投与経路別（経口および非経口）、エンドユーザー別（病院、専門クリニック、放射線センター、在宅医療、およびその他）、流通チャネル別（直接入札、病院薬局、小売薬局、オンライン薬局、およびその他）– 2031年までの業界動向および予測。

神経内分泌腫瘍市場

神経内分泌腫瘍市場の分析と規模

神経内分泌腫瘍市場では、肺、膵臓、消化管などの臓器から発生する腫瘍に対する治療が行われます。たとえば、小細胞肺がんを含む肺神経内分泌腫瘍には、化学療法や免疫療​​法などの専門的な治療が必要です。膵臓 NET には、手術、ペプチド受容体放射性核種療法、または標的薬物治療が必要になる場合があります。消化管 NET には、腫瘍のサイズと広がりに合わせたソマトスタチン類似体、標的療法、または外科的介入が必要になることがよくあります。

Data Bridge Market Researchは、2023年に32億3,202万米ドルだった世界の神経内分泌腫瘍市場は、2024年から2031年の予測期間中に10.4%のCAGRで成長し、2031年には71億3,224万米ドルに達すると予測しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

神経内分泌腫瘍市場の範囲とセグメンテーション  

レポートメトリック

詳細

予測期間

2024年から2031年

基準年

2023

歴史的な年

2022 (2016～2021年にカスタマイズ可能)

定量単位

売上高（百万米ドル）、販売数量（個数）、価格（米ドル）

対象セグメント

分類 (機能的ネットと非機能的ネット)、部位 (肺、膵臓、消化管 (GI)、および虫垂)、グレード (グレード 1、グレード 2、およびグレード 3)、タイプ (診断と治療)、製品 (ソマトスタチン類似体、標的療法、および化学療法)、投与経路 (経口および非経口)、エンドユーザー (病院、専門クリニック、放射線センター、在宅医療、およびその他)、流通チャネル (直接入札、病院薬局、小売薬局、オンライン薬局、およびその他)

対象国

北米では米国、カナダ、メキシコ、ヨーロッパではドイツ、フランス、英国、オランダ、スイス、ベルギー、ロシア、イタリア、スペイン、トルコ、ヨーロッパではその他のヨーロッパ、中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、アジア太平洋地域 (APAC) ではその他のアジア太平洋地域 (APAC)、中東およびアフリカ (MEA) の一部としてのサウジアラビア、UAE、南アフリカ、エジプト、イスラエル、中東およびアフリカ (MEA) の一部としてのその他の中東およびアフリカ (MEA)、南米の一部としてのブラジル、アルゼンチン、南米のその他の地域

対象となる市場プレーヤー

F. Hoffmann-La Roche Ltd (スイス)、Bristol Myers Squibb (米国)、Viatris Inc. (米国)、Thermo Fisher Scientific Inc. (米国)、Novartis AG (スイス)、Regeneron Pharmaceuticals, Inc. (米国)、Sun Pharmaceutical Industries Ltd. (インド)、Teva Pharmaceutical Industries Ltd. (イスラエル)、Eli Lilly and Company (米国)、Lupin (インド)、Exact Sciences Corporation (米国)、Pfizer Inc. (米国)、Ipsen Pharma (フランス)、Advanced Accelerator Applications (フランス)、BioSynthema Inc. (米国)、Bionano Genomics, Inc. (米国)、Illumina, Inc. (米国)、GSK plc (英国)、HUTCHMED (中国)

市場機会
  • 個人のニーズを満たすパーソナライズの需要の高まり
  • 早期診断を強化する高度な画像技術

市場の定義

神経内分泌腫瘍 (NET) は、体全体、特に消化管、膵臓、肺などの臓器に存在する神経内分泌細胞から発生する腫瘍です。これらの腫瘍は、多様な臨床的行動を示し、さまざまなホルモンや生理活性物質を分泌するため、症状が多様で診断が複雑になります。治療法は、腫瘍の特性と病期によって異なります。

世界の神経内分泌腫瘍市場の動向

ドライバー

  • 医療従事者の間で高まる意識

医療従事者は、神経内分泌腫瘍に関する認識の高まりを目の当たりにしています。この高まりは、継続的な研究と教育活動によって促進されています。理解が深まると、専門家はより正確な診断を提供し、それに応じて治療計画を調整することができます。このような進歩は、患者の転帰を改善し、神経内分泌腫瘍をより適切に管理する上で極めて重要であり、最終的には患者のケアと健康の向上に貢献します。

  • 世界的に神経内分泌腫瘍の発生率が上昇

神経内分泌腫瘍市場では、世界的に発生率が著しく増加しています。この増加は、診断技術の向上により、検出と報告が改善されたことによるものです。さらに、ライフスタイル要因と環境の影響も、罹患率の増加に寄与しています。医療専門家と一般の人々の間で認識が高まるにつれて、早期発見と治療戦略への注目が高まり、この高まる健康上の懸念に効果的に対処することの重要性が強調されています。

機会

  • 個人のニーズを満たすパーソナライズの需要の高まり

神経内分泌腫瘍市場では、個々の患者の要件を満たす個別化医療戦略の需要が高まっています。この傾向は、革新的な治療法と標的治療アプローチにとって大きなチャンスをもたらします。特定の患者特性と腫瘍プロファイルに合わせて介入を調整することで、医療提供者は治療結果を最適化し、患者の満足度を向上させることができ、神経内分泌腫瘍管理の進歩の可能性を強調しています。

  • 早期診断を強化する高度な画像技術

神経内分泌腫瘍市場は、陽電子放出断層撮影 (PET) スキャンや機能的 MRI などの高度な画像技術の採用増加の恩恵を受けています。これらの技術により、腫瘍の進行の早期発見と正確なモニタリングが可能になり、タイムリーな介入と個別の治療計画が容易になります。診断精度と治療モニタリングの向上は患者の転帰改善に寄与し、市場の成長を促進し、神経内分泌腫瘍患者への医療提供を強化します。

制約/課題

  • 高額な費用により患者と医療施設のアクセスが制限される

高度な画像診断技術と治療法の高コストは、患者と医療施設のアクセスを制限し、市場の成長を抑制します。この制約は、特にリソースが限られている地域では、タイムリーな診断と最適な管理を妨げます。さらに、医療システムと患者に経済的負担をもたらし、治療開始を遅らせ、神経内分泌腫瘍の治療と診断の全体的な市場拡大を妨げる可能性があります。

  • 標準化の欠如は診断の遅れや不正確さにつながる

神経内分泌腫瘍の診断基準が標準化されていないため、診断と治療の決定にばらつきが生じ、課題が生じています。この不一致により、診断が遅れたり不正確になったりし、患者の転帰に影響を及ぼし、市場の成長を妨げます。明確なガイドラインがなければ、臨床医は患者を効果的に管理するのに苦労し、治療と診断の採用に影響を及ぼし、神経内分泌腫瘍治療の市場全体の拡大を制限する可能性があります。

この世界的な神経内分泌腫瘍市場レポートは、最近の新しい開発、貿易規制、輸出入分析、生産分析、バリュー チェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会の分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリ市場の成長、アプリケーションのニッチと優位性、製品の承認、製品の発売、地理的拡張、市場における技術革新の詳細を提供します。世界的な神経内分泌腫瘍市場の詳細については、アナリスト ブリーフについて Data Bridge Market Research にお問い合わせください。当社のチームが、情報に基づいた市場決定を行い、市場の成長を達成できるようお手伝いします。

最近の動向

  • 2023年4月、ケンブリッジ大学の研究者らはマドリードのスペイン国立がん研究センター（CNIO）と提携し、稀少な神経内分泌腫瘍、すなわち褐色細胞腫および傍神経節腫（PPGL）のゲノム研究で世界的に協力することになった。焦点は、原発性腫瘍の早期診断を可能にし、がん細胞の増殖を阻止し、患者の転帰を改善することを目指す免疫療法にある。
  • 2022年6月、アリセウム・セラピューティクスは、低悪性度および高悪性度の神経内分泌癌の診断と全身標的放射線療法の強化を目的とした2,500万ユーロの多額の資金を投入して設立されました。この投資は、これらの困難な癌に苦しむ患者の治療選択肢を前進させる大きな一歩を意味します。
  • 2022年3月、イプセンは、ソマチュリンオートジェル/ソマチュリンデポ（ランレオチド）の最先端の電子自動注射器に多額の投資を行い、胃腸膵神経内分泌腫瘍、カルチノイド症候群、または先端巨大症の患者に対する投与と注射体験の向上を目指しました。この革新的なデバイスは、治療の提供を前進させ、これらの病状の管理における全体的な患者体験を向上させるというイプセンの取り組みを表しています。
  • 2020年8月、F.ホフマン・ラ・ロシュ社は欧州委員会からロズリートレクの優先販売承認を取得しました。この薬は、成人および12歳以上の小児の進行性非小細胞肺がんの治療薬として指定されています。この規制上のマイルストーンは、さまざまな年齢層にわたるこの困難な病状に対処する上で大きな進歩を意味します。

世界の神経内分泌腫瘍市場の範囲

世界の神経内分泌腫瘍市場は、分類、部位、グレード、タイプ、製品、投与経路、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメントの成長は、業界のわずかな成長セグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供して、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。

分類

  • 機能ネット
  • 機能しないネット

サイト

  • 肺
  • 膵臓
  • 消化管（GI）
  • 付録

 学年

  • グレード1
  • 低悪性度腫瘍
  • グレード2
  • 中悪性度腫瘍
  • 3年生
  • 高悪性度腫瘍

タイプ

  • 診断
  • 処理

製品

  • ソマトスタチン類似体
  • 標的療法
  • チロシンキナーゼ阻害剤
  • mTOR阻害剤
  • 化学療法
  • 代謝拮抗物質
  • アルキル化剤
  • 天然製品

 投与経路

  • オーラル
  • 非経口

 エンドユーザー

  • 病院
  • 専門クリニック
  • 放射線センター
  • 在宅医療
  • その他

流通チャネル

  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 他の

世界の神経内分泌腫瘍市場の地域分析/洞察

世界の神経内分泌腫瘍市場が分析され、市場規模の洞察と傾向が、上記の分類、場所、グレード、タイプ、製品、投与経路、エンドユーザー、流通チャネル別に提供されます。

世界の神経内分泌腫瘍市場レポートでカバーされている国は、北米では米国、カナダ、メキシコ、ヨーロッパではドイツ、フランス、英国、オランダ、スイス、ベルギー、ロシア、イタリア、スペイン、トルコ、その他のヨーロッパ諸国、アジア太平洋地域 (APAC) では中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、その他のアジア太平洋地域 (APAC)、中東およびアフリカ (MEA) の一部としてサウジアラビア、UAE、南アフリカ、エジプト、イスラエル、その他の中東およびアフリカ (MEA)、南米の一部としてブラジル、アルゼンチン、その他の南米です。

北米は、その堅調な消費者市場と高い GDP により、神経内分泌腫瘍市場を支配しています。世界で最も高い家計支出と貿易協定を有する米国は、診断用製品の主要市場として機能し、この地域の主導的地位を固めています。

ヨーロッパでは、発症率の上昇、標的療法の需要の高まり、可処分所得の増加により、ドイツが神経内分泌腫瘍市場をリードしています。これらの要因により、ドイツは、この地域で神経内分泌腫瘍がもたらす課題の増大に対処する上で重要なプレーヤーとしての地位を確立しています。

アジア太平洋地域では、神経内分泌腫瘍市場は中国が主導権を握っていますが、これは、こうした治療にかかる費用をカバーする医療報酬政策と高齢者向けの特典によるものです。これらの要因により、この地域では中国が神経内分泌腫瘍治療で優位に立っています。

レポートの国別セクションでは、市場の現在および将来の動向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、各国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税と貿易ルートの影響も考慮されます。

ヘルスケアインフラの成長 導入基盤と新技術の浸透

世界の神経内分泌腫瘍市場では、各国の医療設備支出の伸び、世界の神経内分泌腫瘍市場向けのさまざまな種類の製品のインストールベース、ライフライン曲線を使用するテクノロジーの影響、医療規制シナリオの変化とそれらが世界の神経内分泌腫瘍市場に与える影響など、詳細な市場分析も提供しています。データは、2016年から2021年までの履歴期間で利用可能です。

競争環境と世界の神経内分泌腫瘍市場シェア分析

世界の神経内分泌腫瘍市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性が含まれます。提供されている上記のデータ ポイントは、世界の神経内分泌腫瘍市場に関連する会社の焦点にのみ関連しています。

世界の神経内分泌腫瘍市場で活動している主要企業は次のとおりです。

  • F. ホフマン・ラ・ロシュ社（スイス）
  • ブリストル マイヤーズ スクイブ（米国）
  • ビアトリス社（米国）
  • サーモフィッシャーサイエンティフィック株式会社（米国）
  • ノバルティスAG（スイス）
  • リジェネロン・ファーマシューティカルズ社（米国）
  • サン・ファーマシューティカル・インダストリーズ（インド）
  • テバ製薬工業株式会社（イスラエル）
  • イーライリリー・アンド・カンパニー（米国）
  • ルピナス（インド）
  • エグザクトサイエンシズコーポレーション（米国）
  • ファイザー社（米国）
  • イプセンファーマ（フランス）
  • 先進加速器アプリケーション（フランス）
  • バイオシンセマ社（米国）
  • バイオナノ・ジェノミクス社（米国）
  • イルミナ社（米国）
  • GSK plc（英国）
  • ハッチメッド（中国）

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of THE GLOBAL Neuroendocrine tumors market
    4. Currency and pricing
    5. LIMITATIONs
    6. MARKETS COVERED
  2. GLOBAL Neuroendocrine tumors market: SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. DBMR TRIPOD DATA VALIDATION MODEL
    5. primary interviews with key opinion leaders
    6. MULTIVARIATE MODELLING
    7. classification LIFELINE CURVE
    8. DBMR MARKET POSITION GRID
    9. vendor share analysis
    10. MARKET end user COVERAGE GRID
    11. secondary sourcEs
    12. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. Pipeline analysis
  6. Pricing Analysis
  7. GLOBAL NEUROENDOCRINE TUMORS MARKET: REGULATIONS
    1. REGULATORY PROCEDURE IN THE U.S.
    2. REGULATORY PROCEDURE IN CANADA
    3. REGULATORY PROCEDURE IN EUROPE
    4. REGULATORY PROCEDURE IN CHINA
    5. REGULATORY PROCEDURE IN MIDDLE EAST AND AFRICA
  8. COMPARITIVE ANALYSIS BETWEEN MONOCLONAL AND POLYCLONAL ANTIBODY
    1. MONOCLONAL ANTIBODY
    2. POLYCLONAL ANTIBODY
  9. Market Overview
    1. drivers
      1. Increased incidence of neuroendocrine tumor cases
      2. Technological advanceMENT for THE detection of neuroendocrine tumors
      3. Growth in the Number of Private Diagnostic Centers and Treatment Providers
      4. Presence of targeted treatment options
      5. Favorable reimbursement policies
    2. RESTRAINTS
      1. High Capital Investments & Low Benefit-Cost Ratio for biomarkers and orphan drugs
      2. Lack of awareness among the population
      3. Unmet needs and access to medical resources in several regions
      4. High cost of Diagnosis
    3. opportunities
      1. Increased Government initiatives
      2. Emerging therapies & development in treatment
      3. Rising collaborations among the market players
    4. challenges
      1. Side effects associated with treatments
      2. Stringent government regulations for THE development OF neuroendocrine tumor drugs
  10. Impact of COVID 19 on Global Neuroendocrine tumors market
    1. Price Impact
    2. Impact of Demand
    3. Impact on supply chain:
    4. Strategic Decisions:
    5. CONCLUSION:
  11. Global neuroendocrine tumors market, BY Classification
    1. overview
    2. non-functional net
    3. Funtional NET
  12. Global neuroendocrine tumors market, BY site
    1. overview
    2. gastrointestinal tract (GI)
    3. lungs
    4. pancreas
  13. Global neuroendocrine tumors market, BY GRADE
    1. overview
    2. Grade 2 (Intermediate-Grade Tumor)
    3. grade 3 (high-grade tumor)
    4. grade 1( low-grade tumor)
  14. Global neuroendocrine tumors market, BY type
    1. overview
    2. DIAGNOSIS
      1. Blood Test
      2. imaging test
        1. CTSCAN
        2. MRI
        3. OTHERS
      3. biopsy
      4. Urine test
      5. Others
    3. treatment
      1. somatostatin analogs
        1. OCTREOTIDE
        2. LANREOTIDE
      2. TARGETED THERAPY
        1. EVEROLIMUS
        2. SUNITINIB
        3. OTHERS
      3. RADIATION THERAPY
        1. EXTERNAL-BEAM RADIATION
        2. INTERNAL-BEAM RADIATION
      4. surgery
        1. CHOLECYSTECTOMY
        2. OTHERS
      5. LIVER-DIRECTED TREATMENT
        1. RADIO FREQUENCY ABLATION (RFA)
        2. HEPATIC ARTERY EMBOLIZATION
        3. RADIOEMBOLIZATION
      6. Peptide Receptor Radionuclide Therapy (PRRT)/ Lutathera
  15. Global neuroendocrine tumors market, BY ROUTE OF ADMINISTRATION
    1. overview
    2. oral
      1. tablets
      2. pills
      3. others
    3. parenteral
      1. subcutaneous
      2. intramuscular
      3. others
  16. Global neuroendocrine tumors market, BY End User
    1. overview
    2. Hospitals
    3. speciality clinics
    4. radiation centers
    5. home healthcare
    6. others
  17. Global neuroendocrine tumors market, BY Distribution Channel
    1. overview
    2. direct tender
    3. hospital pharmacy
    4. retail sales
    5. online pharmacy
    6. others
  18. GLOBAL Neuroendocrine tumors market, by Geography
    1. overview
    2. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. germany
      2. france
      3. U.K.
      4. ITALY
      5. Russia
      6. spain
      7. SWITZERLAND
      8. NETHERLANds
      9. TURKEY
      10. IRELAND
      11. POLAND
      12. AUSTRIA
      13. NORWAY
      14. HUNGARY
      15. LITHUANIA
      16. REST OF EUROPE
    4. Asia pacific
      1. China
      2. Japan
      3. India
      4. Australia
      5. Malaysia
      6. Indonesia
      7. South Korea
      8. Singapore
      9. Philippiness
      10. Thailand
      11. Vietnam
      12. Rest of Asia-Pacific
    5. south america
      1. brazil
      2. argentina
      3. peru
      4. rest of south america
    6. middle east and africa
      1. south africa
      2. saudi arabia
      3. egypt
      4. israel
      5. UAE
      6. kuwait
      7. rest of middle east and africa
  19. Global Neuroendocrine tumors market: COMPANY landscape
    1. company share analysis: Global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  20. SWOT
  21. company profiles
    1. F. HOFFMANN-LA ROCHE LTD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. BRISTOL-MYERS SQUIBB COMPANY
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. VIATRIS INC.
      1. COMPANY SNAPSHOT
      2. Company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. THERMO FISHER SCIENTIFIC INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. NOVARTIS AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. REGENERON PHARMACEUTICALS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. BIONANO GENOMICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. BIOSYNTHEMA INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. CALLISTOPHARMA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. ELI LILLY AND COMPANY
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. EXACT SCIENCES CORPORATION
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. GLAXOSMITHKLINE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. HUTCHISON CHINA MEDITECH LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. IPSEN PHARMA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. ILLUMINA, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. LUPIN
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. MERCK SHARP & DOHME CORP., A SUBSIDIARY OF MERCK & CO., INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. PFIZER INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. SUN PHARMACEUTICAL INDUSTRIES LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. TEVA PHARMACEUTICAL INDUSTRIES LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  22. questionnaire
  23. related reports

表のリスト

TABLE 1 Global Neuroendocrine tumors market, Pipeline Analysis

TABLE 2 Sales Data of oncology market for 2019/2020

TABLE 3 Global Neuroendocrine tumors market, By Classification 2019-2028(USD Million)

TABLE 4 Global Non-Functional NET in Neuroendocrine tumors market, By Classification 2019-2027 (USD Million)

TABLE 5 Global Functional NET in Neuroendocrine tumors market, By Classification 2019-2027 (USD Million)

TABLE 6 Global Neuroendocrine tumors market, By Site 2019-2028 (USD Million)

TABLE 7 Global Gastrointestinal Tract (GI) in Neuroendocrine tumors market, By Site 2019-2028 (USD Million)

TABLE 8 Global Lungs in Neuroendocrine tumors market, By Site 2019-2028 (USD Million)

TABLE 9 Global Pancreas Neuroendocrine tumors market, By Site 2019-2028 (USD Million)

TABLE 10 Global Neuroendocrine tumors market, By Grade 2019-2028 (USD Million)

TABLE 11 Global Grade 2 (Intermediate-Grade Tumor) in Neuroendocrine tumors market, By Grade 2019-2028 (USD Million)

TABLE 12 Global Grade 3 (High-Grade Tumor) in Neuroendocrine tumors market, By Grade 2019-2028 (USD Million)

TABLE 13 Global Neuroendocrine tumors market, By grade 2019-2028 (USD Million)

TABLE 14 Global Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 15 Global Diagnosis in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 16 Global Diagnosis in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 17 Global Imaging Test in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 18 Global Treatment Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 19 Global Treatment in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 20 Global somatostatin analogs in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 21 Global Targeted Therapy in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 22 Global Radiation Therapy in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 23 Global surgery in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 24 Global liver-directed treatment in Neuroendocrine tumors market, By Type 2019-2028 (USD Million)

TABLE 25 Global Neuroendocrine tumors market, By Route of Administration, 2019-2028 (USD Million)

TABLE 26 Global Oral in Neuroendocrine tumors market, By Route of Administration, 2019-2028 (USD Million)

TABLE 27 Global Oral in Neuroendocrine tumors market, By Route of Administration, 2019-2028 (USD Million)

TABLE 28 Global Parenteral in Neuroendocrine tumors market, By Route of Administration, 2019-2028 (USD Million)

TABLE 29 Global Parenteral in Neuroendocrine tumors market, By Route of Administration, 2019-2028 (USD Million)

TABLE 30 Global Neuroendocrine tumors market, By End User, 2019-2028 (USD Million)

TABLE 31 Global Hospitals in Neuroendocrine tumors market, By End User, 2019-2028 (USD Million)

TABLE 32 Global Speciality Clinics in Neuroendocrine tumors market, By End User, 2019-2028 (USD Million)

TABLE 33 Global Radiation Centers in Neuroendocrine tumors market, By End User, 2019-2028 (USD Million)

TABLE 34 global Others in radiotherapy market, By Region, 2018-2027 (USD Million)

TABLE 35 Global Others in Neuroendocrine tumors market, By End User, 2019-2028 (USD Million)

TABLE 36 Global Neuroendocrine tumors market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 37 Global Direct Tender in Neuroendocrine tumors market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 38 Global Hospital Pharmacy in Neuroendocrine tumors market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 39 Global Retail Sales in Neuroendocrine tumors market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 40 Global Online Pharmacy in Neuroendocrine tumors market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 41 Global Others in Neuroendocrine tumors market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 42 GLOBAL NEUROENDOCRINE TUMORS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 north america neuroendocrine tumors market, country, 2021-2028 (USD Million)

TABLE 44 NORTH AMERICA neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 45 north america neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 46 NORTH AMERICA neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 47 NORTH AMERICA neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 48 NORTH AMERICA diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 49 NORTH AMERICa imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 50 NORTH AMERICA treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 51 NORTH AMERICA somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 52 NORTH AMERICA targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 53 NORTH AMERICA radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 54 NORTH AMERICA surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 55 NORTH AMERICA liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 56 NORTH AMERICA neuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 57 NORTH AMERICA oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 58 NORTH AMERICA parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 59 NORTH AMERICA neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 60 NORTH AMERICA parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 61 U.S. neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 62 u.s. neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 63 u.s. neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 64 u.s. neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 65 u.s. diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 66 U.S. imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 67 U.S. treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 68 U.S. somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 69 U.S. targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 70 U.S. radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 71 U.S. surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 72 U.S. liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 73 U.S. neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 74 U.S. oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 75 U.S. parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 76 U.S. neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 77 U.S. parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 78 CANADA neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 79 Canadaneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 80 Canada neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 81 Canada neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 82 Canadadiagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 83 CANADAimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 84 CANADAtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 85 CANADAsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 86 CANADAtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 87 CANADAradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 88 CANADAsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 89 CANADAliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 90 CANADAneuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 91 CANADAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 92 CANADAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 93 CANADAneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 94 CANADAparenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 95 MEXICOneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 96 MEXICO neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 97 Mexico neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 98 Mexico neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 99 MEXICO diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 100 MEXICO imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 101 MEXICO treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 102 MEXICO somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 103 MEXICO targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 104 MEXICO radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 105 MEXICO surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 106 MEXICOliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 107 MEXICOneuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 108 MEXICOoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 109 MEXICOparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 110 MEXICOneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 111 MEXICO neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 112 EUROPE Neuroendocrine tumors market, By Country, 2019-2028 (USD Million)

TABLE 113 EUROPEneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 114 Europeneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 115 EUROPEneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 116 EUROPEneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 117 EUROPEdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 118 Europeimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 119 EUROPEtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 120 EUROPEsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 121 EUROPEtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 122 EUROPEradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 123 EUROPEsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 124 EUROPEliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 125 EUROPEneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 126 EUROPEoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 127 EUROPEparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 128 EUROPEneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 129 EUROPE neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 130 GERMANY neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 131 Germany neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 132 GERMANY neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 133 GERMANYneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 134 GERMANYdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 135 GERMANY imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 136 GERMANY treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 137 GERMANY somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 138 GERMANY targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 139 GERMANY radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 140 GERMANY surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 141 GERMANYliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 142 GERMANYneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 143 GERMANYoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 144 GERMANYparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 145 GERMANYneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 146 GERMANY neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 147 FRANCE neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 148 France neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 149 FRANCE neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 150 FRANCE neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 151 France diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 152 France imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 153 FRANCEtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 154 FRANCEsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 155 FRANCEtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 156 FRANCEradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 157 FRANCEsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 158 FRANCEliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 159 FRANCEneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 160 FRANCEoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 161 FRANCEparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 162 FRANCEneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 163 FRANCE neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 164 U.K. neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 165 U.K. neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 166 U.K. neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 167 U.K. neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 168 U.K. diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 169 U.K. imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 170 U.K.treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 171 U.K.somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 172 U.K.targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 173 U.K.radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 174 U.K.surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 175 U.K.liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 176 U.K.neuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 177 U.K.oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 178 U.K.parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 179 U.K.neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 180 U.K. neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 181 ITALYneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 182 ITALYneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 183 ITALYneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 184 ITALYneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 185 ITALYdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 186 ITALYimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 187 ITALYtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 188 ITALYsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 189 ITALYtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 190 ITALYradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 191 ITALYsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 192 ITALYliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 193 ITALYneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 194 ITALYoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 195 ITALYparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 196 ITALYneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 197 ITALY neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 198 RUSSIA neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 199 RUSSIAneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 200 RUSSIAneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 201 RUSSIAneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 202 RUSSIAdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 203 RUSSIAimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 204 RUSSIAtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 205 RUSSIAsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 206 RUSSIAtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 207 RUSSIAradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 208 RUSSIAsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 209 RUSSIAliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 210 RUSSIAneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 211 RUSSIAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 212 RUSSIAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 213 RUSSIAneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 214 RUSSIA neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 215 SPAIN neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 216 SPAIN NEUROENDOCRINE TUMORS MARKET, By site, 2021-2028 (USD Million)

TABLE 217 SPAIN NEUROENDOCRINE TUMORS MARKET, By grade, 2021-2028 (USD Million)

TABLE 218 SPAIN NEUROENDOCRINE TUMORS MARKET, By Type, 2021-2028 (USD Million)

TABLE 219 SPAINdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 220 SPAINimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 221 SPAINtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 222 SPAINsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 223 SPAINtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 224 SPAINradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 225 SPAINsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 226 SPAINliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 227 SPAIN NEUROENDOCRINE TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 228 SPAINoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 229 SPAINparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 230 SPAIN NEUROENDOCRINE TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 231 SPAIN neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 232 SWITZERLAND neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 233 SWITZERLAND neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 234 SWITZERLANDneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 235 SWITZERLANDneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 236 SWITZERLANDdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 237 SWITZERLANDimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 238 SWITZERLANDtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 239 SWITZERLANDsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 240 SWITZERLANDtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 241 SWITZERLANDradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 242 SWITZERLANDsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 243 SWITZERLANDliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 244 SWITZERLANDneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 245 SWITZERLANDoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 246 SWITZERLANDparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 247 SWITZERLANDneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 248 SWITZERLAND neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 249 NETHERLANDs neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 250 NETHERLANDs neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 251 NETHERLANDs neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 252 NETHERLANDs neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 253 NETHERLANDs diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 254 NETHERLANDs imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 255 NETHERLANDs treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 256 NETHERLANDs somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 257 NETHERLANDs targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 258 NETHERLANDs radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 259 NETHERLANDs surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 260 NETHERLANDs liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 261 NETHERLANDs neuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 262 NETHERLANDs oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 263 NETHERLANDs parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 264 NETHERLANDs neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 265 NETHERLANDs neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 266 Turkey neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 267 Turkey neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 268 Turkey neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 269 Turkey neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 270 Turkey diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 271 Turkey imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 272 Turkey treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 273 Turkey somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 274 Turkey targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 275 Turkey radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 276 Turkey surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 277 Turkey liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 278 Turkey neuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 279 Turkey oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 280 Turkey parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 281 Turkey neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 282 Turkey neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 283 Irelandneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 284 Irelandneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 285 Irelandneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 286 Irelandneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 287 Irelanddiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 288 Irelandimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 289 Irelandtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 290 Irelandsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 291 Irelandtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 292 Irelandradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 293 Irelandsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 294 Irelandliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 295 Irelandneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 296 Irelandoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 297 Irelandparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 298 Irelandneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 299 Ireland neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 300 Polandneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 301 Polandneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 302 Polandneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 303 Polandneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 304 Polanddiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 305 Polandimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 306 Polandtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 307 Polandsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 308 Polandtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 309 Polandradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 310 Polandsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 311 Polandliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 312 Polandneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 313 Polandoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 314 Polandparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 315 Polandneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 316 Poland neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 317 Austrianeuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 318 Austrianeuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 319 Austrianeuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 320 Austrianeuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 321 Austriadiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 322 Austriaimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 323 Austriatreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 324 Austriasomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 325 Austriatargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 326 Austriaradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 327 Austriasurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 328 Austrialiver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 329 Austrianeuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 330 Austriaoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 331 Austriaparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 332 Austrianeuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 333 Austria neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 334 Norwayneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 335 Norwayneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 336 Norwayneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 337 Norwayneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 338 Norwaydiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 339 Norwayimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 340 Norwaytreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 341 Norwaysomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 342 Norwaytargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 343 Norwayradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 344 Norwaysurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 345 Norwayliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 346 Norwayneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 347 Norwayoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 348 Norwayparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 349 Norwayneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 350 Norway neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 351 Hungaryneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 352 Hungaryneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 353 Hungaryneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 354 Hungaryneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 355 Hungarydiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 356 Hungaryimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 357 Hungarytreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 358 Hungarysomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 359 Hungarytargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 360 Hungaryradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 361 Hungarysurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 362 Hungaryliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 363 Hungaryneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 364 Hungaryoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 365 Hungaryparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 366 Hungaryneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 367 Hungary neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 368 Lithuanianeuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 369 Lithuanianeuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 370 Lithuanianeuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 371 Lithuanianeuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 372 Lithuaniadiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 373 Lithuaniaimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 374 Lithuaniatreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 375 Lithuaniasomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 376 Lithuaniatargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 377 Lithuaniaradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 378 Lithuaniasurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 379 Lithuanialiver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 380 Lithuanianeuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 381 Lithuaniaoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 382 Lithuaniaparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 383 Lithuanianeuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 384 Lithuania neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 385 REST OF EUROPE Neuroendocrine tumors market, By classification 2019-2028 (USD Million)

TABLE 386 Lithuanianeuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 387 asia pacific Neuroendocrine tumors market, By Country, 2019-2028 (USD Million)

TABLE 388 ASIA PACIFICneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 389 Asia Pacificneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 390 ASIA PACIFICneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 391 ASIA PACIFICneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 392 ASIA PACIFICdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 393 Asia Pacificimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 394 ASIA PACIFICtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 395 ASIA PACIFICsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 396 ASIA PACIFICtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 397 ASIA PACIFICradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 398 ASIA PACIFICsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 399 ASIA PACIFICliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 400 ASIA PACIFICneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 401 ASIA PACIFICoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 402 ASIA PACIFICparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 403 ASIA PACIFICneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 404 ASIA PACIFIC neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 405 CHINAneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 406 Chinaneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 407 CHINAneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 408 CHINAneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 409 CHINAdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 410 Chinaimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 411 CHINAtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 412 CHINAsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 413 CHINAtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 414 CHINAradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 415 CHINAsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 416 CHINAliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 417 CHINAneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 418 CHINAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 419 CHINAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 420 CHINAneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 421 CHINA neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 422 JAPANneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 423 Japanneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 424 JAPANneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 425 JAPANneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 426 JAPANdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 427 Japanimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 428 JAPANtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 429 JAPANsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 430 JAPANtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 431 JAPANradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 432 JAPANsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 433 JAPANliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 434 JAPANneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 435 JAPANoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 436 JAPANparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 437 JAPANneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 438 JAPAN neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 439 INDIAneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 440 Indianeuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 441 INDIAneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 442 INDIAneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 443 INDIAdiagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 444 Indiaimaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 445 INDIAtreatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 446 INDIAsomatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 447 INDIAtargeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 448 INDIAradiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 449 INDIAsurgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 450 INDIAliver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 451 INDIAneuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 452 INDIAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 453 INDIAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 454 INDIAneuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 455 INDIA neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 456 Australianeuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 457 Australianeuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 458 Australianeuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 459 Australianeuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 460 australia diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 461 AUSTRALIA imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 462 AUSTRALIA treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 463 AUSTRALIA somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 464 AUSTRALIA targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 465 AUSTRALIA radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 466 AUSTRALIA surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 467 AUSTRALIA liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 468 Australiaeuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 469 AUSTRALIAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 470 AUSTRALIAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 471 Australiaeuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 472 australia neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 473 Malaysianeuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 474 Malaysianeuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 475 Malaysianeuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 476 Malaysianeuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 477 Malaysia diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 478 MALAYSIA imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 479 MALAYSIA treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 480 MALAYSIA somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 481 MALAYSIA targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 482 MALAYSIA radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 483 MALAYSIA surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 484 MALAYSIA liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 485 Malaysiaeuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 486 MALAYSIAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 487 MALAYSIAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 488 Malaysiaeuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 489 Malaysia neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 490 Indonesianeuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 491 Indonesianeuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 492 Indonesianeuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 493 Indonesianeuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 494 Indonesia diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 495 INDONESIA imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 496 INDONESIA treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 497 INDONESIA somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 498 INDONESIA targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 499 INDONESIA radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 500 INDONESIA surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 501 INDONESIA liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 502 Indonesiaeuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 503 INDONESIAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 504 INDONESIAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 505 Indonesiaeuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 506 Indonesia neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 507 South Koreaneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 508 South Koreaneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 509 South Koreaneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 510 South Koreaneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 511 South Korea diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 512 SOUTH KOREA imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 513 SOUTH KOREA treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 514 SOUTH KOREA somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 515 SOUTH KOREA targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 516 SOUTH KOREA radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 517 SOUTH KOREA surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 518 SOUTH KOREA liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 519 South Koreaeuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 520 SOUTH KOREAoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 521 SOUTH KOREAparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 522 South Koreaeuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 523 South Korea neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 524 Singaporeneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 525 Singaporeneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 526 Singaporeneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 527 Singaporeneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 528 Singapore diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 529 SINGAPORE imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 530 SINGAPORE treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 531 SINGAPORE somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 532 SINGAPORE targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 533 SINGAPORE radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 534 SINGAPORE surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 535 SINGAPORE liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 536 Singaporeeuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 537 SINGAPOREoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 538 SINGAPOREparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 539 Singaporeeuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 540 Singapore neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 541 Philippinessneuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 542 Philippinessneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 543 Philippinessneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 544 Philippinessneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 545 Philippiness diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 546 PHILIPPINESS imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 547 PHILIPPINESS treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 548 PHILIPPINESS somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 549 PHILIPPINESS targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 550 PHILIPPINESS radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 551 PHILIPPINESS surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 552 PHILIPPINESS liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 553 Philippinesseuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 554 PHILIPPINESSoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 555 PHILIPPINESSparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 556 Philippinesseuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 557 Philippiness neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 558 Thailand neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 559 Thailandneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 560 Thailandneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 561 Thailandneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 562 Thailand diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 563 THAILAND imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 564 THAILAND treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 565 THAILAND somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 566 THAILAND targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 567 THAILAND radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 568 THAILAND surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 569 THAILAND liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 570 Thailandeuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 571 THAILANDoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 572 THAILANDparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 573 Thailandeuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 574 Thailand neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 575 Vietnam neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 576 Vietnamneuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 577 Vietnamneuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 578 Vietnamneuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 579 Vietnam diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 580 VIETNAM imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 581 VIETNAM treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 582 VIETNAM somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 583 VIETNAM targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 584 VIETNAM radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 585 VIETNAM surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 586 VIETNAM liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 587 Vietnameuroendocrine TUMORS MARKET, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 588 VIETNAMoral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 589 VIETNAMparenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 590 Vietnameuroendocrine TUMORS MARKET, By end user, 2021-2028 (USD Million)

TABLE 591 Vietnam neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 592 rest of asia-pacific neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 593 south america neuroendocrine tumors market, country, 2021-2028 (USD Million)

TABLE 594 south america neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 595 south america neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 596 south AMERICA neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 597 south AMERICA neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 598 south AMERICA diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 599 south AMERICa imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 600 south AMERICA treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 601 south AMERICA somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 602 south AMERICA targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 603 south AMERICA radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 604 south AMERICA surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 605 south AMERICA liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 606 south AMERICA neuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 607 south AMERICA oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 608 south AMERICA parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 609 south AMERICA neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 610 south AMERICA parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 611 brazil neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 612 brazil neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 613 brazil neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 614 brazil neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 615 brazil diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 616 brazil imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 617 brazil treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 618 brazil somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 619 brazil targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 620 brazil radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 621 brazil surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 622 brazil liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 623 brazil neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 624 brazil oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 625 brazil parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 626 brazil neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 627 brazil parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 628 argentina neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 629 argentina euroendocrine TUMORS MARKET, By site, 2021-2028 (USD Million)

TABLE 630 argentina neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 631 argentina neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 632 argentina diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 633 argentina imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 634 argentina treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 635 argentina somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 636 argentina targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 637 argentina radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 638 argentina surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 639 argentina liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 640 argentina neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 641 argentina oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 642 argentina parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 643 argentina neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 644 argentina parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 645 peru neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 646 peru neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 647 peru neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 648 peru neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 649 peru diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 650 peru imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 651 peru treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 652 peru somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 653 peru targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 654 peru radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 655 peru surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 656 peru liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 657 peru neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 658 peru oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 659 peru parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 660 peru neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 661 peru parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 662 rest of south america neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 663 Middle East and Africa neuroendocrine tumors market, country, 2021-2028 (USD Million)

TABLE 664 middle east and africa neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 665 middle east and africa neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 666 middle east and africa neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 667 middle east and africa neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 668 middle east and africa diagnosis in NEUROENDOCRINE TUMORS MARKET, BY TYPE, 2021-2028 (USD MILLION

TABLE 669 middle east and africa imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 670 middle east and africa treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 671 middle east and africa somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 672 middle east and africa targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 673 middle east and africa radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 674 middle east and africa surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 675 middle east and africa liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 676 middle east and africa neuroendocrine tumors market, By ROUTE OF ADMINISTRATION , 2021-2028 (USD Million)

TABLE 677 middle east oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 678 middle east and africa parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 679 middle easta and africa neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 680 middle east and africa parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 681 south africa neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION )

TABLE 682 south africa neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 683 south africa neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 684 south africa neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 685 south africa diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 686 south africa imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 687 south africa treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 688 south africa somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 689 south africa targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 690 south africa radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 691 south africa surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 692 south africa liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 693 south africa neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 694 south africa oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 695 south africa parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 696 south africa neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 697 south africa parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 698 Saudi Arabia neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 699 saudi arabia neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 700 saudi arabia neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 701 saudi arabia neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 702 saudi arabia diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 703 saudi arabia imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 704 saudi arabia treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 705 saudi arabia somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 706 saudi arabia targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 707 saudi arabia radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 708 saudi arabia surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 709 saudi arabia liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 710 saudi arabia neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 711 saudi arabia oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 712 saudi arabia parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 713 saudi arabia neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 714 saudi arabia parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 715 egypt euroendocrine TUMORS MARKET, By classification, 2021-2028 (USD MILLION)

TABLE 716 egypt neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 717 egypt neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 718 egypt neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 719 egypt diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 720 egypt imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 721 egypt treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 722 egypt somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 723 egypt targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 724 egypt radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 725 egypt surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 726 egypt liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 727 egypt neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 728 egypt oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 729 egypt parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 730 egypt neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 731 egypt parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 732 israel euroendocrine TUMORS MARKET, By classification, 2021-2028 (USD MILLION)

TABLE 733 israel neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 734 israel neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 735 israel neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 736 israel diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 737 israel imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 738 israel treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 739 israel somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 740 israel targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 741 israel radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 742 israel surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 743 israel liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 744 israel neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 745 israel oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 746 israel parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 747 israel neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 748 israel parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 749 UAE euroendocrine TUMORS MARKET, By classification, 2021-2028 (USD MILLION)

TABLE 750 uae neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 751 uae neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 752 uae neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 753 uae diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 754 uae imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 755 uae treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 756 uae somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 757 uae targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 758 uae radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 759 uae surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 760 uae liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 761 uae neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 762 uae oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 763 uae parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 764 uae neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 765 uae parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 766 kuwait neuroendocrine tumors market, By classification, 2021-2028 (USD MILLION)

TABLE 767 kuwait neuroendocrine tumors market, By site, 2021-2028 (USD Million)

TABLE 768 kuwait neuroendocrine tumors market, By grade, 2021-2028 (USD Million)

TABLE 769 kuwait neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 770 kuwait diagnosis in neuroendocrine tumors market, By Type, 2021-2028 (USD Million)

TABLE 771 kuwait imaging test in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 772 kuwait treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 773 kuwait somatostatin analogs in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 774 kuwait targeted therapy in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 775 kuwait radiation THERAPY in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 776 kuwait surgery in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 777 kuwait liver directed treatment in neuroendocrine tumors market, By type, 2021-2028 (USD Million)

TABLE 778 kuwait neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 779 kuwait oral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 780 kuwait parenteral in neuroendocrine tumors market, By ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

TABLE 781 kuwait neuroendocrine tumors market, By end user, 2021-2028 (USD Million)

TABLE 782 kuwait parenteral in neuroendocrine tumors market, By distribution channel, 2021-2028 (USD Million)

TABLE 783 rest of middle east and africa euroendocrine TUMORS MARKET, By classification, 2021-2028 (USD MILLION)

図表一覧

FIGURE 1 GLOBAL Neuroendocrine tumors market: segmentation

FIGURE 2 GLOBAL Neuroendocrine tumors market: data triangulation

FIGURE 3 GLOBAL NEUROENDOCRINE TUMORS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL Neuroendocrine tumors market: global VS REGIONAL ANALYSIS

FIGURE 5 GLOBAL Neuroendocrine tumors market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Neuroendocrine tumors market: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL Neuroendocrine tumors market: DBMR MARKET POSITION GRID

FIGURE 8 Global neuroendocrine tumors market: vendor share analysis

FIGURE 9 Global neuroendocrine tumors market: MARKET end user COVERAGE GRID

FIGURE 10 GLOBAL Neuroendocrine tumors market: SEGMENTATION

FIGURE 11 increased incidence of neuroendocrine tumors cases is expected to drive the GLOBAL Neuroendocrine tumors market in the forecast period of 2021 to 2028

FIGURE 12 non-funtional net segment is expected to account for the largest share of the Global Neuroendocrine tumors market in 2021 & 2028

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE Global neuroendocrine tumors market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR neuroendocrine tumors MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 FIVE YEAR SURVIVAL RATE OF PANCREATIC NEUROENDOCRINE TUMOR BETWEEN 2010- 2016

FIGURE 16 INCIDENCE OF NEO-ENDOCRINE NEOPLASM IN CHINA, EUROPE AND U.S.

FIGURE 17 Global neuroendocrine tumors market: BY classification, 2020

FIGURE 18 GLOBAL neuroendocrine tumors market, BY classification, 2020-2028 (USD MILLION)

FIGURE 19 GLOBAL neuroendocrine tumors market: BY classification, CAGR (2021-2028)

FIGURE 20 GLOBAL neuroendocrine tumors market: BY classification, LIFELINE CURVE

FIGURE 21 Global neuroendocrine tumors market: BY site, 2020

FIGURE 22 GLOBAL neuroendocrine tumors market, BY site, 2020-2028 (USD MILLION)

FIGURE 23 GLOBAL neuroendocrine tumors market: BY site, CAGR (2021-2028)

FIGURE 24 GLOBAL neuroendocrine tumors market: BY site, LIFELINE CURVE

FIGURE 25 Global neuroendocrine tumors market: BY grade, 2020

FIGURE 26 GLOBAL neuroendocrine tumors market, BY grade, 2020-2028 (USD MILLION)

FIGURE 27 GLOBAL neuroendocrine tumors market: BY grade, CAGR (2021-2028)

FIGURE 28 GLOBAL neuroendocrine tumors market: BY grade, LIFELINE CURVE

FIGURE 29 Global neuroendocrine tumors market: BY type, 2020

FIGURE 30 GLOBAL neuroendocrine tumors market, BY type, 2020-2028 (USD MILLION)

FIGURE 31 GLOBAL neuroendocrine tumors market: BY type, CAGR (2021-2028)

FIGURE 32 GLOBAL neuroendocrine tumors market: BY type, LIFELINE CURVE

FIGURE 33 Global neuroendocrine tumors market: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 34 GLOBAL neuroendocrine tumors market, BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 35 GLOBAL neuroendocrine tumors market: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028)

FIGURE 36 GLOBAL neuroendocrine tumors market: BY ROUTE OF ADMINSTRATION, LIFELINE CURVE

FIGURE 37 Global neuroendocrine tumors market: BY end user, 2020

FIGURE 38 GLOBAL neuroendocrine tumors market, BY end user, 2020-2028 (USD MILLION)

FIGURE 39 GLOBAL neuroendocrine tumors market: BY end user, CAGR (2021-2028)

FIGURE 40 GLOBAL neuroendocrine tumors market: BY end user, LIFELINE CURVE

FIGURE 41 Global neuroendocrine tumors market: BY distribution channel, 2020

FIGURE 42 GLOBAL neuroendocrine tumors market, BY distribution channel, 2020-2028 (USD MILLION)

FIGURE 43 GLOBAL neuroendocrine tumors market: BY distribution channel, CAGR (2021-2028)

FIGURE 44 GLOBAL neuroendocrine tumors market: BY distribution channel, LIFELINE CURVE

FIGURE 45 GLOBAL Neuroendocrine tumors market: SNAPSHOT (2020)

FIGURE 46 GLOBAL Neuroendocrine tumors market: BY Region (2020)

FIGURE 47 GLOBAL Neuroendocrine tumors market: BY Region (2020 & 2028)

FIGURE 48 GLOBAL Neuroendocrine tumors market: BY Region (2020 & 2028)

FIGURE 49 GLOBAL Neuroendocrine tumors market: BY classification (2021-2028)

FIGURE 50 NORTH AMERICA neuroendocrine tumors market: SNAPSHOT (2020)

FIGURE 51 NORTH AMERICA neuroendocrine tumors market: BY country (2020)

FIGURE 52 NORTH AMERICA neuroendocrine tumors market: BY country (2021 & 2028)

FIGURE 53 NORTH AMERICA neuroendocrine tumors market: BY country (2021 & 2028)

FIGURE 54 NORTH AMERICA neuroendocrine tumors market: BY classification (2021-2028)

FIGURE 55 EUROPE neuroendocrine tumors market: SNAPSHOT (2020)

FIGURE 56 EUROPE neuroendocrine tumors market: BY COUNTRY (2020)

FIGURE 57 EUROPE neuroendocrine tumors market: BY COUNTRY (2021 & 2028)

FIGURE 58 EUROPE neuroendocrine tumors market: BY COUNTRY (2021 & 2028)

FIGURE 59 EUROPE neuroendocrine tumors market: BY classification (2021-2028)

FIGURE 60 Asia pacific neuroendocrine tumors market: SNAPSHOT (2020)

FIGURE 61 Asia pacific neuroendocrine tumors market: BY COUNTRY (2020)

FIGURE 62 Asia pacific neuroendocrine tumors market: BY COUNTRY (2021 & 2028)

FIGURE 63 Asia pacific neuroendocrine tumors market: BY COUNTRY (2021 & 2028)

FIGURE 64 Asia pacific neuroendocrine tumors market: BY strains (2021-2028)

FIGURE 65 south america neuroendocrine tumors market: SNAPSHOT (2020)

FIGURE 66 south america neuroendocrine tumors market: BY country (2020)

FIGURE 67 south america neuroendocrine tumors market: BY country (2021 & 2028)

FIGURE 68 south america and Africa neuroendocrine tumors market: BY country (2021 & 2028)

FIGURE 69 south america neuroendocrine tumors market: BY classification (2021-2028)

FIGURE 70 Middle East and Africa neuroendocrine tumors market: SNAPSHOT (2020)

FIGURE 71 Middle East and Africa neuroendocrine tumors market: BY country (2020)

FIGURE 72 Middle East and Africa neuroendocrine tumors market: BY country (2021 & 2028)

FIGURE 73 Middle East and Africa neuroendocrine tumors market: BY country (2021 & 2028)

FIGURE 74 Middle East and Africa neuroendocrine tumors market: BY classification (2021-2028)

FIGURE 75 Global neuroendocrine tumors market: company share 2020 (%)

FIGURE 76 north america neuroendocrine tumors market: company share 2020 (%)

FIGURE 77 europe neuroendocrine tumors market: company share 2020 (%)

FIGURE 78 Asia-Pacific neuroendocrine tumors market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Neuroendocrine Tumors Market size will be worth USD 7,132.24 million by 2031 during the forecast period.
The Neuroendocrine Tumors Market growth rate is 10.4% during the forecast period.
The Growing Awareness among Healthcare Professionals and Rising Incidence of Neuroendocrine Tumors Globally are the growth drivers of the Neuroendocrine Tumors Market.
The classification, site, grade, type, product, route of administration, end-user, and distribution channel are the factors on which the Neuroendocrine Tumors Market research is based.
The major companies in the Neuroendocrine Tumors Market are F. Hoffmann-La Roche Ltd (Switzerland), Bristol Myers Squibb (U.S.), Viatris Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Novartis AG (Switzerland), Regeneron Pharmaceuticals, Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Lupin (India), Exact Sciences Corporation (U.S.), Pfizer Inc. (U.S.), Ipsen Pharma (France), Advanced Accelerator Applications (France), BioSynthema Inc. (U.S.), Bionano Genomics, Inc.U.S.), Illumina, Inc. (U.S.), GSK plc (U.K.), HUTCHMED (China).

関連ページを閲覧する

Banner